rs3816334
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001103146.3(GIGYF2):c.2940A>G(p.Gln980=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.64 in 1,601,720 control chromosomes in the GnomAD database, including 332,040 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.68 ( 35868 hom., cov: 32)
Exomes 𝑓: 0.64 ( 296172 hom. )
Consequence
GIGYF2
NM_001103146.3 synonymous
NM_001103146.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.01
Genes affected
GIGYF2 (HGNC:11960): (GRB10 interacting GYF protein 2) This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
?
Variant 2-232844096-A-G is Benign according to our data. Variant chr2-232844096-A-G is described in ClinVar as [Benign]. Clinvar id is 518336.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-232844096-A-G is described in Lovd as [Benign].
BP7
?
Synonymous conserved (PhyloP=1.01 with no splicing effect.
BA1
?
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.727 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GIGYF2 | NM_001103146.3 | c.2940A>G | p.Gln980= | synonymous_variant | 24/29 | ENST00000373563.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GIGYF2 | ENST00000373563.9 | c.2940A>G | p.Gln980= | synonymous_variant | 24/29 | 1 | NM_001103146.3 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.683 AC: 103784AN: 151868Hom.: 35824 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
103784
AN:
151868
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.650 AC: 157128AN: 241644Hom.: 52536 AF XY: 0.632 AC XY: 82393AN XY: 130466
GnomAD3 exomes
AF:
AC:
157128
AN:
241644
Hom.:
AF XY:
AC XY:
82393
AN XY:
130466
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.636 AC: 921477AN: 1449734Hom.: 296172 Cov.: 38 AF XY: 0.628 AC XY: 452438AN XY: 720936
GnomAD4 exome
AF:
AC:
921477
AN:
1449734
Hom.:
Cov.:
38
AF XY:
AC XY:
452438
AN XY:
720936
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.683 AC: 103878AN: 151986Hom.: 35868 Cov.: 32 AF XY: 0.684 AC XY: 50846AN XY: 74294
GnomAD4 genome
?
AF:
AC:
103878
AN:
151986
Hom.:
Cov.:
32
AF XY:
AC XY:
50846
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Parkinson disease 11, autosomal dominant, susceptibility to Benign:3
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Sep 21, 2015 | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | Jun 22, 2017 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at